Des Atouts Changement Date
Abbott USD 108.25B 968M 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Bio-Rad Laboratories USD 10.78B 531.1M 2026-09
EDAP TMS EUR 72.06M 10.6M 2026-03
J&J USD 197.42B 3.64B 2026-09
Mesa Laboratories USD 434.85M 4.5M 2025-12
OraSure Technologies USD 360.55M 18.62M 2026-06
Plus Therapeutics USD 14.03M 5.89M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Siemens EUR 169.87B 2.32B 2026-09
Thermo Fisher Scientific USD 114.23B 1.06B 2026-09
Tosoh JPY 1.5T 28.86B 2026-09
Trinity Biotech USD 101.92M 3.25M 2026-03
Veracyte USD 1.57B 86.89M 2026-09